Literature DB >> 21251466

Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?

Mike Makris, Joost J Van Veen.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21251466      PMCID： PMC3096854          DOI： 10.2450/2011.0111-10

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  14 in total

1.  A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.

Authors:  H G Watson; T Baglin; S L Laidlaw; M Makris; F E Preston
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

Review 2.  The management of coumarin-induced over-anticoagulation Annotation.

Authors:  M Makris; H G Watson
Journal:  Br J Haematol       Date:  2001-08       Impact factor: 6.998

3.  Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation.

Authors:  Aaron Lubetsky; Ron Hoffman; Reuven Zimlichman; Amiram Eldor; Joseph Zvi; Viktor Kostenko; Benjamin Brenner
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

Review 4.  The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  P H B Bolton-Maggs; D J Perry; E A Chalmers; L A Parapia; J T Wilde; M D Williams; P W Collins; S Kitchen; G Dolan; A D Mumford
Journal:  Haemophilia       Date:  2004-09       Impact factor: 4.287

5.  Guidelines on oral anticoagulation (warfarin): third edition--2005 update.

Authors:  T P Baglin; D M Keeling; H G Watson
Journal:  Br J Haematol       Date:  2006-02       Impact factor: 6.998

6.  Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects.

Authors:  Brett E Skolnick; David R Mathews; Naum M Khutoryansky; Anthony E Pusateri; Marcus E Carr
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

7.  Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma.

Authors:  Shan Yuan; Chris Ferrell; Wayne L Chandler
Journal:  Thromb Res       Date:  2006-08-02       Impact factor: 3.944

8.  Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

Authors:  M Makris; M Greaves; W S Phillips; S Kitchen; F R Rosendaal; E F Preston
Journal:  Thromb Haemost       Date:  1997-03       Impact factor: 5.249

9.  Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage.

Authors:  Davide Imberti; Giovanni Barillari; Chiara Biasioli; Marina Bianchi; Laura Contino; Rita Duce; Marco D'Incà; Maria Cristina Gnani; Elisa Mari; Walter Ageno
Journal:  Blood Transfus       Date:  2011-01-13       Impact factor: 3.443

10.  Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.

Authors:  I Pabinger; B Brenner; U Kalina; S Knaub; A Nagy; H Ostermann
Journal:  J Thromb Haemost       Date:  2008-01-15       Impact factor: 5.824
View more
  10 in total

1.  Three- or four-factor prothrombin complex concentrate for emergency anticoagulation reversal: what are we really looking for?

Authors:  Marco Marietta; Paola Pedrazzi; Mario Luppi
Journal:  Blood Transfus       Date:  2011-07-20       Impact factor: 3.443

2.  3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Severe Bleeding: A Multicenter, Retrospective, Propensity-Matched Pilot Study.

Authors:  G Morgan Jones; Michael J Erdman; Keaton S Smetana; Kerry M Mohrien; Joseph E Vandigo; Lucas Elijovich
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

3.  Evaluation of a fixed, weight-based dose of 3-factor prothrombin complex concentrate without adjunctive plasma following warfarin-associated intracranial hemorrhage.

Authors:  Kerry M Mohrien; G Morgan Jones; Andrew B Boucher; Lucas Elijovich
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

4.  Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.

Authors:  Giovanni Barillari; Samantha Pasca; Alfredo Barillari; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2011-09-22       Impact factor: 3.443

5.  Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.

Authors:  Peter Toth; Joost Jair van Veen; Kate Robinson; Rhona Murray Maclean; Kingsley Kevin Hampton; Stuart Laidlaw; Michael Makris
Journal:  Blood Transfus       Date:  2012-10-10       Impact factor: 3.443

6.  Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.

Authors:  S Horstmann; T Rizos; M Lauseker; M Möhlenbruch; E Jenetzky; W Hacke; Th Steiner; R Veltkamp
Journal:  J Neurol       Date:  2013-05-05       Impact factor: 4.849

Review 7.  A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective.

Authors:  Valery V Wojciechowski; Daniela Calina; Konstantinos Tsarouhas; Alexander V Pivnik; Alexander A Sergievich; Vladimir V Kodintsev; Ekaterina A Filatova; Eren Ozcagli; Anca Oana Docea; Andreea Letitia Arsene; Eliza Gofita; Christina Tsitsimpikou; Aristidis M Tsatsakis; Kirill S Golokhvast
Journal:  Daru       Date:  2017-04-17       Impact factor: 3.117

8.  A Retrospective Comparison of 3-Factor Prothrombin Complex Concentrate Products for Warfarin Reversal.

Authors:  G Morgan Jones; Brandon Cave; Ryan Cook
Journal:  Neurohospitalist       Date:  2020-03-04

9.  Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.

Authors:  Thibaut Desmettre; Emilie Dehours; Charles-Marc Samama; Suchin Jhundoo; Frédéric Pujeau; Christian Guillaudin; Claudine Hecquart; Pierre Clerson; Jean Charles Crave; Roland Jaussaud
Journal:  Crit Care       Date:  2012-10-04       Impact factor: 9.097

10.  Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal.

Authors:  Scott A Chapman; Eric D Irwin; Nada M Abou-Karam; Nichole M Rupnow; Katherine E Hutson; Jeffrey Vespa; Robert M Roach
Journal:  World J Emerg Surg       Date:  2014-04-15       Impact factor: 5.469
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.